Skip to Content

Join the 'Benign Prostatic Hyperplasia (BPH)' group to help and get support from people like you.

Benign Prostatic Hyperplasia (BPH) News

Related terms: Benign Prostatic Enlargement, Benign Prostatic Hypertrophy (BPH), Enlarged prostate, Prostate, enlarged, BPH, Benign Prostatic Hypertrophy

Cancer Experts Criticize Report on Rising Prostate Cancer Numbers

Posted 21 Jul 2016 by

THURSDAY, July 21, 2016 – A headline-grabbing report earlier this week claimed that new cases of advanced prostate cancer in the United States had skyrocketed 72 percent in the past decade. And the study authors from Northwestern University suggested the increase might be tied to a 2012 recommendation that men not be screened for prostate cancer by using the prostate-specific antigen (PSA) test. PSA, a protein produced by cells of the prostate gland, is often elevated in men with prostate cancer. However, the validity and usefulness of the PSA test has been debated for years. But on Wednesday, the American Cancer Society challenged the validity of the Northwestern researchers' findings. Dr. Otis Brawley, the society's chief medical officer, said the methodology used by the Northwestern researchers was flawed, thereby making the study's conclusions flawed. "This study makes a dramatic ... Read more

Related support groups: Cancer, Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Prostate Tumor - Benign

Number of Advanced Prostate Cancer Cases Soars: U.S. Study

Posted 19 Jul 2016 by

TUESDAY, July 19, 2016 – New cases of advanced prostate cancer in the United States have skyrocketed 72 percent in the past decade, a troubling new study shows. The biggest increase was among men aged 55 to 69, with a 92 percent jump seen over 10 years. This rise is worrisome because these men are the ones who may benefit most from screening and early treatment, the researchers said. "The increase could be because the disease is becoming more aggressive, or it could be because there is less screening being done, but we don't know why," said lead researcher Dr. Edward Schaeffer. He is chair of urology at Northwestern University's Feinberg School of Medicine in Chicago. It's possible that prostate cancer may be getting more aggressive, Schaeffer said, but statistics also show that fewer men are being screened. That's the probable consequence of a 2012 recommendation by the U.S. ... Read more

Related support groups: Cancer, Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Prostate Tumor - Benign

Could Nasal Spray Curtail Nighttime Bathroom Trips?

Posted 8 May 2016 by

SUNDAY, May 8, 2016 – Countless people – often men with enlarged prostates – need to visit the bathroom during the night. But help could soon be at hand in the form of a nasal spray, new research suggests. A spritz of a synthetic hormone, already used by bed-wetting kids, might benefit older people struggling with the problem called nocturia. "Nocturia is very common in patients over 50 years old, and can cause significant problems by causing loss of sleep, and injury due to falls," said study lead author Dr. Jed Kaminetsky. The millions of people with nocturia wake up two or more times a night to urinate. Besides an enlarged prostate, Kaminetsky said, common causes are bladder problems, poor circulation and obesity. Kaminetsky is a clinical assistant professor of urology at NYU Langone Medical Center in New York City. In the United States there's no approved drug to treat the ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostatitis, DDAVP, Desmopressin, Minirin, Primary Nocturnal Enuresis, DDAVP Nasal, DDAVP Rhinal Tube, Stimate, Nocturnal Polyuria, Prostate Tumor - Benign

New Prostate Technique May Help Men's Nighttime Urination

Posted 4 Apr 2016 by

MONDAY, April 4, 2016 – Waking often in the night to urinate is a common problem among men who have an enlarged prostate, but an innovative new treatment has shown some promise in easing the problem, researchers are reporting. The procedure, called prostatic artery embolization (PAE), involves placing microscopic spheres in the arteries that supply blood to the prostate gland to partially block the blood flow. Reducing blood flow to the prostate causes the gland to soften and shrink, said lead researcher Dr. Sandeep Bagla, an interventional radiologist at the Vascular Institute of Virginia, in Woodbridge. In their new study, Bagla and his colleagues show that PAE improves symptoms in men suffering from nocturia – waking up repeatedly during the night to urinate. "Their urinary symptoms bothered them considerably less, and their quality of life also showed marked improvement," Bagla ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Overactive Bladder, Urinary Incontinence, Prostatitis, Urinary Retention, Primary Nocturnal Enuresis, Prostate Tumor - Benign

'Suicide Gene Therapy' Plus Radiation Fights Prostate Cancer: Study

Posted 14 Dec 2015 by

MONDAY, Dec. 14, 2015 – A combination of "suicide gene therapy" and radiation is highly effective in treating prostate cancer, researchers say. In this type of gene therapy, a patient's cancer cells are genetically modified so that they prompt the person's immune system to attack the cells, the Houston Methodist Hospital researchers explained. "We have created a vaccine with the patient's own cancer cells, a treatment that complements, and may even enhance, what we can achieve with traditional radiation and hormonal therapies," study senior author Dr. E. Brian Butler, chair of the department of radiation oncology, said in a hospital news release. The study included 62 patients who were divided into two groups. One group, who had cancer cells confined to the prostate, received radiation treatment. The second group, who had more aggressive prostate cancer, received both radiation and ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Nausea/Vomiting - Radiation Induced, History - Radiation Therapy, Genitourinary Surgical and Other Conditions, Prostate Tumor - Benign

Low-Risk Prostate Cancer Often Not Monitored Closely

Posted 4 Dec 2015 by

FRIDAY, Dec. 4, 2015 – Most men with low-risk prostate cancer who choose "watchful waiting" instead of aggressive treatment may not be followed as closely as they should be, a new study suggests. This puts them in danger of their cancer progressing or spreading undetected, the researchers warned. "This is really an important finding, because before patients and their doctors decide to pursue active surveillance as a management option for prostate cancer, both the physician and patient should agree on a follow-up schedule to closely monitor the cancer," study first author Dr. Karim Chamie, an assistant professor of urology at University of California, Los Angeles, said in a university news release. The study included almost 38,000 men who were diagnosed with prostate cancer between 2004 and 2007, and followed through 2009. Of the approximately 3,600 men who chose close monitoring ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Diagnosis and Investigation, Prostate Tumor - Benign

Relaxed Guidelines on PSA Testing Might Miss Aggressive Tumors: Study

Posted 22 Sep 2015 by

TUESDAY, Sept. 22, 2015 – Relaxed guidelines on prostate cancer screening may delay diagnosis and treatment of aggressive tumors, a new study suggests. In 2011, the U.S. Preventive Services Task Force recommended against routine prostate specific antigen (PSA) testing, to curb over-diagnosis and overtreatment of prostate cancer. Since then, PSA screening has dropped by 28 percent, the researchers report. "On the positive side, there is a lot of prostate cancer that we don't need to know about," said lead researcher Dr. Daniel Barocas, an assistant professor of urologic surgery at Vanderbilt University, in Nashville, Tenn. These are low-risk cancers that most men will not die of, and the treatment can be more harmful than the cancer, he explained. "To that extent, the guideline had a beneficial effect," Barocas said. "On the negative side, we seem to be missing intermediate and ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Diagnosis and Investigation, Prostate Tumor - Benign

Too Few Men With Low-Risk Prostate Cancers Get 'Watch and Wait' Approach

Posted 30 Jun 2015 by

TUESDAY, June 30, 2015 – A wide majority of U.S. men with low-risk prostate cancer are being treated for the disease even though "active surveillance" is an option, a new report finds. Active surveillance – or watchful waiting – is the careful monitoring of prostate cancer for progression of the cancer that would indicate a need for treatment. Men in the Northeast and on the West Coast were especially likely to have active surveillance rather than cancer treatment, potentially sparing them from complications associated with treatment. The study data was collected in 2010 and 2011, and a lot has changed since that time in regard to the popularity of active surveillance, experts noted. Active surveillance is "gaining acceptance among urologists and patients," said study co-author Dr. Hui Zhu, chief of urology at the Louis Stokes Cleveland VA Medical Center in Ohio. "Age-appropriate men ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Prostatitis, Prostate Tumor - Benign

Treating Gum Disease Might Help Prostate Symptoms: Study

Posted 22 May 2015 by

FRIDAY, May 22, 2015 – Treating gum disease may help reduce symptoms of prostate inflammation, which can make urination difficult, a small study suggests. Previous research has shown a link between gum disease and prostate inflammation – called prostatitis. The study included 27 men, age 21 and older, who had prostatitis and moderate to severe gum disease. The men underwent treatment for gum disease and showed significant improvement in their gums within four to eight weeks, the study authors said. The men received no treatment for their prostatitis, but symptoms of the condition improved in 21 of 27 of them after their gum disease was treated, according to the study published recently in the journal Dentistry. "This study shows that if we treat the gum disease, it can improve the symptoms of prostatitis and the quality of life for those who have the disease," corresponding author Dr. ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostatitis, Gingivitis, Periodontitis, Prostate Tumor - Benign

New Therapy May Shrink Enlarged Prostate With Fewer Side Effects: Study

Posted 24 Mar 2014 by

MONDAY, March 24, 2014 – A new noninvasive procedure may bring long-term relief from symptoms caused by an enlarged prostate, a new study suggests. As men age, the prostate gland grows larger and may begin to press on the urethra. Enlarged prostate affects more than half of men by age 60 and causes symptoms such as frequent urination, weak urine stream and a persistent feeling of having to urinate. Surgery is the standard treatment for the condition, but can cause complications such as sexual dysfunction and impotence, experts note. The new treatment is called prostate artery embolization. "Prostate artery embolization is a promising therapy that has been performed outside the United States to improve men's symptoms," explained Dr. Man Hon, chief of interventional radiology at Winthrop University Hospital in Mineola, N.Y. "This procedure works by closing the blood supply to the ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH)

Blood Vessel Treatment Might Reduce Symptoms of Enlarged Prostate

Posted 22 Jan 2014 by

WEDNESDAY, Jan. 22, 2014 – A new nonsurgical treatment for enlarged prostate might help ease symptoms such as frequent urination at night, Brazilian researchers report. Enlarged prostate – formally known as benign prostate hyperplasia – affects most men as they age, including more than half by age 60 and 90 percent by age 85. Problems caused by enlarged prostate include frequent urination, weak urine stream and a constant feeling of having to urinate. The new treatment – called prostate artery embolization – shrinks the prostate by temporarily blocking blood flow to the arteries that feed it, the researchers said, and can be done using a local anesthetic. The findings were scheduled to be reported Wednesday at the International Symposium on Endovascular Therapy, in Miami. Doctors at the University of Sao Paolo said they have used prostate artery embolization to treat 120 patients ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH)

New Device Approved for Enlarged Prostate

Posted 16 Sep 2013 by

MONDAY, Sept. 16 – The UroLift system has been approved by the U.S. Food and Drug Administration to treat low or blocked urine flow in men aged 50 and older who have an enlarged prostate. The prostate is a walnut-sized gland that's right below the bladder in males. When the gland becomes enlarged, as tends to happen in older men, it can restrict the flow of urine. The new device, which helps prevent the prostate from pressing on the urethra, was evaluated in clinical studies involving 274 men between the ages of 49 and 86. Participants given the device reported fewer symptoms of enlarged prostate and a better quality of life, the FDA said. The most common adverse reactions included pain or burning during urination, blood in the urine and incomplete emptying of the bladder. The UroLift system is produced by NeoTract Inc., based in Pleasanton, Calif. More information To learn more about ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH)

18-Year Study Finds Drug Cut Prostate Cancer Risk

Posted 14 Aug 2013 by

WEDNESDAY, Aug. 14 – A drug used to treat enlarged prostate and male pattern baldness also reduces a man's risk of prostate cancer by nearly a third, according to a large new study. The findings on nearly 19,000 men also overturn earlier concerns that treatment with finasteride – the agent in the prostate drug Proscar and the hair-loss drug Propecia – might promote the development of more virulent prostate cancers in men who contract the disease, researchers said. Finasteride did not affect overall survival rates or survival rates after diagnosis with prostate cancer for men who did and did not receive the drug, said study lead author Dr. Ian Thompson, a urologist and professor at the University of Texas Health Science Center. "If indeed the more high-grade cancers in the men taking finasteride were real, we would expect to find a higher death rate," Thompson said. "The survival of ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Finasteride, Propecia, Proscar, Androgenetic Alopecia

New Procedure May Shrink Enlarged Prostate Without Surgery

Posted 15 Apr 2013 by

MONDAY, April 15 – Men who need treatment for an enlarged prostate may soon have a new nonsurgical option, a small, early study suggests. Called prostatic artery embolization (PAE), the technique uses a catheter threaded into an artery in the leg. The catheter is guided to the artery that supplies blood to the prostate. Then, tiny beads are injected into the artery, which temporarily block the blood supply to the prostate. The temporary loss of blood supply causes the prostate to shrink, relieving symptoms, according to study lead author Dr. Sandeep Bagla. What's more, the new treatment doesn't appear to have the same risk of serious complications, such as incontinence and impotence, that often accompany enlarged prostate treatment. "This is fantastic news for the average man with benign prostatic hyperplasia. Many men decline current treatments because of the risks. But, for the ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Tumor - Benign

Drug Used to Prevent Prostate Cancer Won't Lower Quality of Life

Posted 12 Sep 2012 by

WEDNESDAY, Sept. 12 – Proscar (finasteride), a drug used to treat an enlarged prostate, does not reduce the quality of life of men who use it for a prolonged period of time, found a new study funded by the U.S. National Cancer Institute. Published Sept. 12 in the Journal of the National Cancer Institute, the research involved men aged 55 and older enrolled in a seven-year randomized clinical trial looking at the drug's possible use for prostate cancer prevention. Researchers from the Fred Hutchinson Cancer Research Center in Seattle, led by Carol Moinpour of the public health sciences division, examined three areas of patients' quality of life. Proscar did not significantly affect the men's physical functioning, mental health or vitality, according to a journal news release. Participants completed questionnaires three months before the study and six months after the study began. They ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Finasteride, Propecia, Proscar

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Prostatitis, Prostate Tumor - Benign, Renal and Genitourinary Disorders

Related Drug Support Groups

Cialis, Flomax, tamsulosin, Avodart, finasteride, doxazosin, prazosin, terazosin, tadalafil, view more... Rapaflo, Cardura, Jalyn, alfuzosin, Proscar, saw palmetto, dutasteride, Uroxatral, Hytrin, silodosin, Cardura XL, Minipress, nettles, dutasteride / tamsulosin, Prostate SR, Carduran, Doxadura, Cascor